BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17376417)

  • 1. Nanoconjugate based on polymalic acid for tumor targeting.
    Ljubimova JY; Fujita M; Khazenzon NM; Lee BS; Wachsmann-Hogiu S; Farkas DL; Black KL; Holler E
    Chem Biol Interact; 2008 Jan; 171(2):195-203. PubMed ID: 17376417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.
    Lee BS; Fujita M; Khazenzon NM; Wawrowsky KA; Wachsmann-Hogiu S; Farkas DL; Black KL; Ljubimova JY; Holler E
    Bioconjug Chem; 2006; 17(2):317-26. PubMed ID: 16536461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
    Fujita M; Lee BS; Khazenzon NM; Penichet ML; Wawrowsky KA; Patil R; Ding H; Holler E; Black KL; Ljubimova JY
    J Control Release; 2007 Oct; 122(3):356-63. PubMed ID: 17630012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.
    Fujita M; Khazenzon NM; Ljubimov AV; Lee BS; Virtanen I; Holler E; Black KL; Ljubimova JY
    Angiogenesis; 2006; 9(4):183-91. PubMed ID: 17109197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
    Inoue S; Ding H; Portilla-Arias J; Hu J; Konda B; Fujita M; Espinoza A; Suhane S; Riley M; Gates M; Patil R; Penichet ML; Ljubimov AV; Black KL; Holler E; Ljubimova JY
    Cancer Res; 2011 Feb; 71(4):1454-64. PubMed ID: 21303974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.
    Ding H; Helguera G; Rodríguez JA; Markman J; Luria-Pérez R; Gangalum P; Portilla-Arias J; Inoue S; Daniels-Wells TR; Black K; Holler E; Penichet ML; Ljubimova JY
    J Control Release; 2013 Nov; 171(3):322-9. PubMed ID: 23770212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymalic acid-based nano biopolymers for targeting of multiple tumor markers: an opportunity for personalized medicine?
    Ljubimova JY; Ding H; Portilla-Arias J; Patil R; Gangalum PR; Chesnokova A; Inoue S; Rekechenetskiy A; Nassoura T; Black KL; Holler E
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24962356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
    Ding H; Inoue S; Ljubimov AV; Patil R; Portilla-Arias J; Hu J; Konda B; Wawrowsky KA; Fujita M; Karabalin N; Sasaki T; Black KL; Holler E; Ljubimova JY
    Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18143-8. PubMed ID: 20921419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood-Brain Barrier.
    Israel LL; Braubach O; Galstyan A; Chiechi A; Shatalova ES; Grodzinski Z; Ding H; Black KL; Ljubimova JY; Holler E
    ACS Nano; 2019 Feb; 13(2):1253-1271. PubMed ID: 30633492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.
    Ljubimova JY; Fujita M; Ljubimov AV; Torchilin VP; Black KL; Holler E
    Nanomedicine (Lond); 2008 Apr; 3(2):247-65. PubMed ID: 18373429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid).
    Patil R; Portilla-Arias J; Ding H; Konda B; Rekechenetskiy A; Inoue S; Black KL; Holler E; Ljubimova JY
    Int J Mol Sci; 2012; 13(9):11681-11693. PubMed ID: 23109877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
    Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
    Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).
    Patil R; Portilla-Arias J; Ding H; Inoue S; Konda B; Hu J; Wawrowsky KA; Shin PK; Black KL; Holler E; Ljubimova JY
    Pharm Res; 2010 Nov; 27(11):2317-29. PubMed ID: 20387095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
    Ljubimova JY; Portilla-Arias J; Patil R; Ding H; Inoue S; Markman JL; Rekechenetskiy A; Konda B; Gangalum PR; Chesnokova A; Ljubimov AV; Black KL; Holler E
    J Drug Target; 2013 Dec; 21(10):956-967. PubMed ID: 24032759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-guided tumour-specific nanoparticle delivery via adenosine A1 receptor.
    Dai T; Li N; Han F; Zhang H; Zhang Y; Liu Q
    Biomaterials; 2016 Mar; 83():37-50. PubMed ID: 26773664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer.
    Altinoğlu EI; Russin TJ; Kaiser JM; Barth BM; Eklund PC; Kester M; Adair JH
    ACS Nano; 2008 Oct; 2(10):2075-84. PubMed ID: 19206454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme.
    Patil R; Galstyan A; Sun T; Shatalova ES; Butte P; Mamelak AN; Carico C; Kittle DS; Grodzinski ZB; Chiechi A; Ding H; Black KL; Ljubimova JY; Holler E
    Biomaterials; 2019 Jun; 206():146-159. PubMed ID: 30933776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
    Jiang X; Xin H; Ren Q; Gu J; Zhu L; Du F; Feng C; Xie Y; Sha X; Fang X
    Biomaterials; 2014 Jan; 35(1):518-29. PubMed ID: 24125772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.